NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GlycoSpot

GlycoSpot

Private
DenmarkFrontier & Industrial Techhttps://www.glycospot.dk/

Last Round

Strategic

Mar 27, 2025

Total Funding Raised

$270,000

Company Overview

GlycoSpot is a biotechnology company that develops application-specific enzyme test methods that are fast to implement and easy to use for companies in the food and beverage industry.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Biotech Equipment, Quality Management

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

enzyme activity testingenzyme assaysat-line testingrapid enzyme analysisenzyme test kitsportable labprocess analytical technologyPATpoint-of-need testingfood quality controlbiotech equipmenthigh-throughput screeningcustom assay developmentclean-in-place validationportable spectrophotometer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlycoSpot Comparables

Compare GlycoSpot with similar companies based on industry and business-model similarity.

GlycoSpot comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CDR s.r.l.
80%
Neogen Corporation
76%
SIRION Biotech
70%

GlycoSpot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 27, 2025

Key People

Founding team and executive leadership

Michael Stanley Pedersen

Chief Executive Officer

Executive Team

GlycoSpot Investors

Notable investors and investment history

GlycoSpot investors
InvestorRounds
Innovation Fund DenmarkGrant
Danish Tech ChallengeAccelerator
CapnovaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Grew 27% QoQ, from 15 to 19 employees.

  • Feb 18, 2026

    Grew 73% QoQ, from 11 to 19 employees.

GlycoSpot Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GlycoSpot Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GlycoSpot's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenmark
Employee Range18
Year Founded2014
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.